Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

7 MINS AGO - MarketWatch

A Must Read - Share

Pfizer shares rise after new $11 billion share buyback program

NEW YORK (MarketWatch) -- Pfizer shares rose 1.4% in after-hours trade Thusday after the blue-chip drug maker said it has authorized a new $11 billion share buyback program, to be "utilized over time." That is in addition to the $1.3 billion left in its previous repurchase program. The company also said it keep its quarterly dividend at 26 cents a ...

Tags: Pfizer shares rise after new $11 billion share buyback program,  Pfizer Latest News

17 MINS AGO - MarketWatch

A Must Read - Share

Pfizer sets new $11 bln share buyback plan

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Tags: Pfizer sets new $11 bln share buyback plan,  Pfizer Latest News

8 HOURS AGO - Zero Hedge

A Must Read - Share

Frontrunning: October 23

Canada PM vows crackdown after capital shocked by fatal attacks (Reuters) Canada Gunman Was Convert to Islam With Criminal Record (BBG) Some U.S. hospitals weigh withholding care to Ebola patients (Reuters) But... Great rotation... Bond funds stock up on Treasuries in prep for market shock (Reuters) Saudis at War With Islamic State Confront Echo of Kingdom’s Past (BBG) EU’s Top ...

Tags: Frontrunning: October 23,  Pfizer Latest News

OCT 22, 2014 - TheStreet

A Must Read - Share

Third Point's Daniel Loeb Tells Amgen it's Time to Break up

Third Point LLC hedge fund manager Daniel Loeb, a major shareholder in Amgen Inc. , is telling the big biotech it should break into two separate companies to "unlock hidden value." The idea would be to split Amgen into a one company that would sell its legacy drugs, such as Enbrel, that fights autoimmune disorders like psoriasis and rheumatoid arthritis, ...

Tags: Third Point's Daniel Loeb Tells Amgen it's Time to Break up,  Pfizer Latest News

OCT 22, 2014 - TheStreet

A Must Read - Share

Why GlaxoSmithKline (GSK) Stock Is Up Today

NEW YORK (TheStreet) -- Shares of GlaxoSmithKline are up 2.04% to $44.52 in pre-market trade afterathe U.K.'s largest drug maker pledged to cut costs and will explore a spin off of its HIV business after reporting third-quarter earnings that beat analyst estimates, Bloomberg reports. The company will reduce expenses by 1 billion pounds over three years, with half of the ...

Tags: Why GlaxoSmithKline (GSK) Stock Is Up Today,  Pfizer Latest News